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Abstract
Persistent infections with hepatitis C virus (HCV) may result in life-threatening liver disease, including cirrhosis and cancer,
and impose an important burden on human health. Understanding how the virus is capable of achieving persistence in the
majority of those infected is thus an important goal. Although HCV has evolved multiple mechanisms to disrupt and block
cellular signaling pathways involved in the induction of interferon (IFN) responses, IFN-stimulated gene (ISG) expression is
typically prominent in the HCV-infected liver. Here, we show that Toll-like receptor 3 (TLR3) expressed within uninfected
hepatocytes is capable of sensing infection in adjacent cells, initiating a local antiviral response that partially restricts HCV
replication. We demonstrate that this is dependent upon the expression of class A scavenger receptor type 1 (MSR1). MSR1
binds extracellular dsRNA, mediating its endocytosis and transport toward the endosome where it is engaged by TLR3,
thereby triggering IFN responses in both infected and uninfected cells. RNAi-mediated knockdown of MSR1 expression
blocks TLR3 sensing of HCV in infected hepatocyte cultures, leading to increased cellular permissiveness to virus infection.
Exogenous expression of Myc-MSR1 restores TLR3 signaling in MSR1-depleted cells with subsequent induction of an
antiviral state. A series of conserved basic residues within the carboxy-terminus of the collagen superfamily domain of MSR1
are required for binding and transport of dsRNA, and likely facilitate acidification-dependent release of dsRNA at the site of
TLR3 expression in the endosome. Our findings reveal MSR1 to be a critical component of a TLR3-mediated pattern
recognition receptor response that exerts an antiviral state in both infected and uninfected hepatocytes, thereby limiting
the impact of HCV proteins that disrupt IFN signaling in infected cells and restricting the spread of HCV within the liver.
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Introduction
Hepatitis C virus (HCV) is an hepatotropic, positive-strand
RNA virus classified within the Flaviviridae family [1]. It is an
important human pathogen since most individuals fail to eliminate
the virus when first infected. This results in persistent infection and
a chronic inflammatory state within the liver that leads over time
to clinically significant complications including progressive liver
fibrosis, cirrhosis, and hepatocellular carcinoma. The mechanisms
underlying these events are only partially understood. The single-
stranded RNA (ssRNA) HCV genome encodes a large polyprotein
precursor of approximately 3000 amino acid residues. This is
cleaved co- and post-translationally into at least 10 mature
proteins, at least 3 of which contribute to the virus structure (core,
and two envelope proteins, E1 and E2), with the remaining 7
proteins generally considered to be nonstructural in nature (p7,
NS2, NS3, NS4A, NS4B, NS5A, and NS5B). NS5B is an RNA-
dependent RNA polymerase and the catalytic core of a large
macromolecular, membrane-bound replicase complex that directs
replication of the viral RNA, producing double-stranded RNA
(dsRNA) replication intermediates as well as new viral genomes.
These viral RNAs are recognized as pathogen-associated molec-
ular patterns (PAMPs) by innate immune sensors in host cells, but
exactly which sequences and how these RNAs are sensed remains
only partly elucidated [2].
In general, dsRNAs produced by viruses are recognized by
several classes of cellular pattern recognition receptors, including
retinoic acid-inducible gene I (RIG-I)-like helicases that are
expressed within the cytoplasm, or Toll-like receptors (TLRs),
such as TLR-3 that is expressed within and signals from a late
endosomal compartment in several different cell types, including
hepatocytes [3,4,5,6]. The engagement of these receptors by viral
RNAs results in the induction of interferon (IFN)-b synthesis
through separate downstream signaling pathways that utilize
unique adaptor molecules but result in the common activation of
the transcription factors NF-kB and IFN regulatory factor 3 (IRF-
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IFN-inducible genes, including IFN-stimulated gene (ISG)15,
ISG56, and others, through both autocrine and paracrine
signaling involving the Janus kinase/signal transducer and
activator of transcription (JAK/STAT) pathway. RIG-I, and the
related cytosolic helicase, myeloid differentiation-associated gene 5
(MDA5) and TLR3 differ substantially in their ligand specificities.
RIG-I recognizes short dsRNA molecules and ssRNA with a 59-
triphosphate, while MDA5 recognizes lengthy dsRNA [5,8]. In
addition, the roles played by RIG-I (which is generally constitu-
tively expressed) and MDA5 (IFN-inducible) in recognition of
RNA viruses appear to vary by virus type. RIG-I is primarily
responsible for innate immune recognition of paramyxoviruses,
influenza virus and Japanese encephalitis virus, while MDA5 is
thought to be critical for the recognition of encephalomyocarditis
virus and possibly other picornaviruses [5]. TLR3 recognizes
dsRNA molecules greater than 40–50 bp in length and also
mediates the induction of antiviral responses in cells infected with
a wide variety of RNA viruses, including West Nile virus,
rhinovirus, respiratory syncytial virus, vesicular stomatitis virus,
lymphocytic choriomeningitis virus and influenza virus [9,10].
However, unlike the cytosolic RIG-I-like helicases, TLR3 initiates
signaling from within the endosome in a process that is dependent
upon acidification of the endosome [11,12].
In HCV-infected cells, the 59-triphosphate of genomic RNA is
recognized by RIG-I, as is a poly-U/UC segment near the 39 end
of the genome that serves as a PAMP [13,14]. This results in the
induction of an IFN response shortly after infection of cells [14].
However, RIG-I-initiated signaling is subsequently blocked since
NS3/4A, the major HCV protease, proteolytically cleaves the
essential RIG-I adaptor protein, mitochondrial antiviral signaling
protein (MAVS) [14,15,16]. The only continuous cell lines that
support robust HCV replication are derived from Huh-7 human
hepatoma cells, which like many transformed hepatocytes are
TLR3 null [17]. However, HCV infection similarly induces an
early antiviral response in RIG-I-defective Huh-7.5 cells in which
TLR3 expression has been reconstituted [4]. As with RIG-I
signaling, TLR3 signaling is also blocked as viral proteins
accumulate and NS3/4A mediates cleavage of an essential
adaptor protein, in this case Toll-like receptor adaptor molecule 1
(TICAM-1, a.k.a. TRIF) [4,18]. How TLR3 is able to sense
HCV infection is uncertain, since double-stranded HCV RNA is
detected primarily adjacent to ER membranes in association with
the nonstructural protein, NS5A, or juxtaposed to cytoplasmic
lipid droplets [19], while TLR3, as described above, senses
dsRNA and initiates signaling only from within late endosomes
[11,12].
One possibility is that dsRNA replication intermediates are
released into the extracellular milieu by HCV-infected cells and,
like poly(I:C) added to the medium of cultured cells, subsequently
sensed by TLR3. Since TLR3 is unable to bind extracellular
dsRNA on the cell surface [12], this would require a receptor
molecule to direct the endocytosis and trafficking of dsRNA to the
late endosome. Scavenger receptors of several different classes,
including C-type lectin domain-containing receptors such as the
oxidized low density lipoprotein (LDL) receptor (ORL-1), or class
A scavenger receptors such as macrophage scavenger receptor 1
(MSR1), have been suggested to fulfill this function, transporting
dsRNA from the surface of cells to the endosome where it is sensed
by TLR3 [20,21,22]. The epidermal growth factor receptor
(EGFR) also plays an essential role in TLR3 signaling, but this
appears to occur at a later step, following the engagement of
TLR3 by dsRNA within the endosome [23].
Here, we show that MSR1 is essential for TLR3 sensing of
HCV infection in cells derived from human hepatocytes, and that
it mediates the establishment of a localized antiviral response in
neighboring, uninfected cells that restricts the replication of virus
in cell culture. Since uninfected hepatocytes are not subject to the
myriad mechanisms that virally-encoded HCV proteins have
evolved to disrupt the induction of IFN responses [2], these
observations reveal a mechanism that may explain both the
significant levels of ISG expression that typify the HCV-infected
liver [24], as well as the fact that only a small minority of
hepatocytes are infected by HCV in human liver [25].
Results
Replication intermediates trigger TLR3 signaling in HCV-
infected cells
While TLR3 is expressed and functional in primary cultures of
human hepatocytes, Huh-7 cells and their derivatives have a
TLR3-null phenotype [4,17]. Thus, to establish an HCV-
permissive cell line in which we could study viral interactions
with the TLR3 signaling pathway, we reconstituted TLR3
expression in Huh-7.5 cells, which are also RIG-I-deficient
[4,26]. Using this, and related cell lines, we demonstrated
previously that HCV infection is sensed by TLR3, resulting in
an early antiviral response [4]. However, HCV ultimately restricts
TLR3 signaling as the NS3/4A protease mediates cleavage of
TICAM-1 as viral proteins accumulate in abundance [4,18]. To
further confirm that TLR3 induces a functional antiviral response
against HCV, we compared the number of colonies of viable cells
originating from TLR3-competent Huh7.5-TLR3 cells transfected
with a dicistronic, genome-length HCV replicon that expresses
neomycin phosphotransferase [pTat2ANeo/H77S, 27] versus
similarly transfected TLR3-null Huh-7.5 cells reconstituted with
non-functional TLR3 mutants. As expected, the number of G418-
resistant colonies arising from Huh7.5-TLR3 cells was significantly
lower than from several related, TLR3-null Huh-7.5 cell lines:
Huh-7.5-Vect (empty vector), 2DTIR (TLR3 lacking the TIR
domain required for downstream signaling), and 2H539E and
2N541A (point mutations in the ectodomain of TLR3 that restrict
its ability to bind dsRNA) (Supplementary Fig. S1). Consistent
with these results, quantitative real-time PCR demonstrated
Author Summary
Persistent hepatitis C virus (HCV) infection is an important
cause of fatal cirrhosis and liver cancer in humans. While
viral disruption of interferon (IFN) signaling pathways may
contribute to the persistence of HCV, IFN-stimulated gene
(ISG) expression is often prominent within the infected
liver. We show here that this is due, at least in part, to Toll-
like receptor 3 sensing of HCV mediated by class A
scavenger receptor type 1 (MSR1)-dependent endocytosis
and transport of extracellular viral double-stranded RNA
(dsRNA) allowing it to be engaged by TLR3 in the late
endosome. TLR3 expressed within uninfected cells is
capable of sensing HCV infection in neighboring infected
cells in a process that is dependent upon the dsRNA-
scavenging activity of MSR1, resulting in the induction of a
localized functional antiviral response. This contributes to
the ISG expression that typifies the chronically-infected
liver, as it occurs within cells that do not express HCV
proteins that disrupt IFN signaling. TLR3 signaling thus
limits the spread of virus within the liver, potentially
explaining why only a small fraction of hepatocytes are
infected with HCV in vivo.
MSR1 Facilitates TLR3 Sensing of Hepatitis C Virus
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mRNAs in Huh7.5-TLR3 cells following infection with a
laboratory strain of HCV (HJ3-5 virus) (Fig. 1A, left and center
panels). Similar increases were not observed in Huh-7.5 cells
expressing the signaling-incompetent TLR3 mutants H539E or
N541A. Importantly, prior UV inactivation of the virus (UV-
HCV) almost completely eliminated the increase in ISG56 mRNA
(Fig. 1A, right panel). On the basis of these and our previously
published results [4], we conclude that TLR3 senses HCV
infection and induces the expression of a functional antiviral state
in Huh7.5-TLR3 cells, and that this requires active replication of
the virus. This is consistent with a recent report indicating that
TLR3-mediated induction of proinflammatory cytokines by HCV
also requires active replication of virus [28].
To better understand these results, we examined the ability of in
vitro synthesized HCV RNAs to stimulate TLR3 signaling. Since
replication of the virus is required to initiate signaling, we reasoned
that TLR3 signaling follows its engagement by dsRNA molecules
produced by transcription of negative-strand RNA intermediates,
rather than multiple structured RNA elements that are known to
exist within the 59 and 39 untranslated regions as well as in the core
and NS5B protein-coding regions of the positive-strand genome
[29]. To test this, we synthesized full-length positive- and negative-
strand viral RNAs by in vitro transcription using as template an
Figure 1. TLR3 senses double-stranded RNA products of HCV replication in human hepatocytes. (A) Quantitative RT-PCR analysis of (left)
IFN-b and (center and right) ISG56 mRNA in Huh7.5-TLR3 cells infected with HCV. Cells were infected with HCV (HJ3-5) or UV-inactivated HCV at an
m.o.i. of 1 for 72 hrs, prior to extraction of RNA and measurement of IFN-b and ISG56 mRNA. Statistical comparisons were made between mock- and
HCV-infected cultures (left and center panels), or between samples indicated by bars (right panel): * p#0.02, ** p#0.001. (B) Agarose gel
electrophoresis of in vitro transcribed HCV RNAs (top panel) before or (bottom panel) after S1 nuclease treatment. M: DNA standards ladder; lane 1,
positive-strand HCV RNA; lane 2, negative-strand HCV RNA; lane 3, annealed double-stranded HCV RNA. (C) Quantitative RT-PCR analysis of ISG56
mRNA in (left) PH5CH8 and (right) Huh7.5/TLR3 cells treated with 50 mg/ml of ssRNA or dsRNA for 6 hrs prior to extraction of RNA. Statistical
comparisons were made with cultures not treated with RNA: * p#0.02, ** p#0.001. (D) (left panel) Immunoblot analysis of ISG15 expression induced
by synthetic HCV dsRNA in PH5CH8 cells previously transduced with lentivirus vectors expressing non-targeting (NT) or TLR3-specific shRNAs. b-actin
was included as a loading control. (right panel) Similar immunoblots of Huh7.5-TLR3 cells treated with HCV dsRNA, either with or without prior S1
nuclease digestion. In both panels, cell lysates were prepared for immunoblotting 24 hrs after addition of dsRNA. (E) HCV RNA co-
immunoprecipitates with Flag-TLR3 from lysates of HCV-infected Huh7.5-TLR3 cells. (top panel) Agarose gel electrophoresis showing detection of
HCV-specific RNA by RT-PCR in anti-Flag (lanes 2, 4 and 6), or isotype control (mouse IgG1, lanes 1, 3 and 5), immunoprecipitates prepared from
lysates of Huh7.5-TLR3 cells (lanes 1 and 2), Huh7.5-H539E cells (lanes 3 and 4), or Huh7.5-H539E cells (lanes 5 and 6), infected with HJ3-5 virus
(m.o.i.=1) for 72 hrs. RNA extracted from mock or HCV-infected Huh-7.5 cells was assayed in parallel in the RT-PCR reaction as negative and positive
controls, respectively (lanes 7 and 8). (bottom panel) Anti-Flag immunoblots of the respective immunoprecipitates.
doi:10.1371/journal.ppat.1003345.g001
MSR1 Facilitates TLR3 Sensing of Hepatitis C Virus
PLOS Pathogens | www.plospathogens.org 3 May 2013 | Volume 9 | Issue 5 | e1003345infectious molecular clone of the genotype 2a JFH1 strain (Fig. 1B,
upper panel, lanes 1 and 2), and annealed these to produce HCV
dsRNA (Fig. 1B, lane 3). As anticipated, the dsRNA products
produced by annealing the two ssRNAs were highly heterogenous,
resulting in a smear when separated by agarose gel electrophoresis.
However, a small amount of what appeared to be full-length
dsRNA was generated (Fig. 1B, arrow). While the positive- and
negative-sense ssRNAs were degraded by S1 nuclease, this dsRNA
was S1 nuclease-resistant, confirming that the complementary in
vitro synthesized HCV RNAs anneal to produce dsRNA (Fig. 1B,
lower panel). Importantly, only the nuclease-resistant dsRNA
induced transcription of ISG56 mRNA when added to the
medium of PH5CH8 cells, a T-antigen transformed, human
hepatocyte line that naturally expresses TLR3, or Huh7.5-TLR3
cells [30] (Fig. 1C, left and right panels). HCV dsRNA also
induced ISG15 protein expression in PH5CH8 and Huh7.5-
TLR3 cells (Fig. 1D). Prior transfection of PH5CH8 cells with
shRNA targeting TLR3 eliminated the induction of ISG15 protein
expression by HCV dsRNA (Fig. 1D, left panel), confirming that
ISG15 induction was mediated through TLR3. Prior digestion of
the dsRNA with S1 nuclease did not alter the pattern of ISG15
induction (Fig. 1D right panel). Collectively, these data indicate
that S1-resistant, double-stranded synthetic HCV RNA is capable
of triggering an antiviral response through TLR3, while highly
structured RNA elements of the single-stranded genome are not
sensed by TLR3. In part, this may be due to the length of the
synthetic dsRNAs, which mimic very lengthy dsRNA intermedi-
ates produced during replication of the 9.7 kb HCV genome
(Fig. 1B) and are much longer than the stable helices present in the
ssRNA. While the minimum length of dsRNA required for
recognition by the TLR3 ectodomain is on the order of 40 to 50
base pairs [31], we have observed that TLR3 is substantially more
responsive to high-molecular weight (1.5–8.0 kb) versus low
molecular weight poly(I:C) (0.2–1.0 kb) (Supplementary Fig. S2).
Consistent with the induction of a TLR3-mediated antiviral
response by HCV, we detected formation of a TLR3-HCV RNA
complex in Huh7.5-TLR3 cells infected with HJ3-5 virus. This
was accomplished by immunoprecipitating TLR3 from lysates of
infected Huh7.5-TLR3 cells with an anti-Flag antibody, and
subjecting RNA extracted from the precipitates to RT-PCR
specific for HCV RNA. Viral RNA was readily detected in anti-
Flag precipitates prepared from lysates of infected Huh7.5-TLR3
cells (Fig. 1E, lane 2). While somewhat less Flag product was
evident in immunoblots of precipitates from cells expressing
TLR3-H539E or TLR3-N541A, TLR3 mutants deficient in
binding dsRNA [4], HCV RNA was not detected in these
precipitates (Fig. 1E, lanes 4 and 6). Taken together, these results
indicate that dsRNA produced in membrane-bound replicase
complexes during HCV replication is transported to the late
endosome where it is engaged by TLR3. Subsequent experiments
focused on the mechanism by which dsRNA traffics to the
endosome.
Macrophage scavenger receptor 1 (MSR1) is required for
TLR3 engagement by HCV RNA
Recent studies suggest that class A scavenger receptors,
including ‘‘macrophage’’ scavenger receptor 1 (MSR1, class A
scavenger receptor type 1, transcript variant 1), are expressed in a
variety of cell types and serve as the dominant receptors mediating
endocytosis of dsRNA in fibroblasts [20,22]. Class A scavenger
receptors recognize a broad range of ligands including acetylated
LDL, and lipopolysaccharide (LPS) produced by Gram-positive
bacteria, and have been shown to mediate endocytosis of both
ssRNA and dsRNA [22,32]. We thus hypothesized that dsRNA
could be released into the extracellular milieu by hepatocytes
infected with HCV, where it could be bound by scavenger
receptors expressed on the cell surface and subsequently trans-
ported to the endosome for recognition by TLR3. To confirm that
MSR1, and possibly other members of the class A scavenger
receptor family, are expressed by human hepatocytes, we utilized
RT-PCR to ascertain the presence of mRNA transcripts for these
proteins in PH5CH8 cells. Transcripts encoding MSR1
(SCARA1, transcript variant 1, referred to generally as
‘‘MSR1’’), scavenger receptor class A member 3 (SCARA3,
transcript variants 1 and 2), SCARA4 (a.k.a. collectin sub-family
member 12, COLEC12), and SCARA5 (a putative class A
scavenger receptor) transcripts were readily detected (Fig. 2A).
Transcripts for MSR1 transcript variant 2 (referred to as ‘‘SR-
AII’’), and MARCO (a.k.a. SCARA2) were not detected, or were
present only in very low abundance. MSR1 and SCARA3,
Figure 2. Scavenger receptor class A family transcript profiling
of human hepatocyte-derived cell lines. (A) RT-PCR detection of
class A scavenger receptor mRNAs in total cellular RNAs extracted from
PH5CH8 cells transduced to express (‘‘NT’’) a non-targeting shRNA
(PH5CH8/shNT cells), or (‘‘T’’) MSR1-specific shRNA (PH5CH8/shMSR1
cells). The parental PH5CH8 cells are T-antigen transformed normal
adult human hepatocytes. Primers specific for MSR1 (SCARA1) transcript
variant 1 (MSR1, SR-AI, or CD204) and transcript variant 2 (SR-AII),
MARCO (SCARA2), SCARA3 (transcript variants 1 and 2), SCARA4, and
SCARA5 (a putative scavenger receptor class A family member) were
identical to those used by DeWitte-Orr et al. [22]. PCR was carried
through 35 cycles prior to separation of products on an agarose gel. (B)
Similar class A scavenger receptor transcript profiling of Huh-7.5 cells
derived from a human hepatocellular carcinoma, and 293FT cells
(Invitrogen). *MSR1 has two transcript variants: variant 1 is commonly
referred to as ‘‘MSR1’’, as we refer to it here, but is otherwise known at
SCARA1 or SR-AI. Transcript variant 2 is referred to as SR-AII. See text for
additional details. **MARCO, macrophage receptor with collagenous
structure, is otherwise known as SCARA2.
doi:10.1371/journal.ppat.1003345.g002
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(Fig. 2B, top panel). However, in contrast to PH5CH8 cells, SR-
AII transcripts were also evident in Huh-7.5 cells, while SCARA5
transcripts were absent.
Consistent with these results, immunoblots demonstrated
expression of MSR1 in both Huh7.5-TLR3 and PH5CH8 cells
(Fig. 3A). To determine whether it plays a role in TLR3 signaling
in these hepatocyte-derived cell lines, we depleted MSR1 by
transducing Huh7.5-TLR3 cells (Huh7.5-TLR3/shMSR1 cells)
and PH5CH8 cells (PH5CH8/shMSR1 cells) with lentiviruses
expressing MSR1-specific shRNA. Immunoblots demonstrated
modest depletion of MSR1 in both Huh7.5-TLR3/shMSR1 cells
(63% depletion estimated by quantitation of the Odyssey infrared
fluorescence signal against b-actin control) and PH5CH8/
shMSR1 cells (55% depletion). RT-PCR confirmed MSR1
knockdown in the PH5CH8 cells, and demonstrated that it was
specific and without effect on SCARA3, SCARA4, or SCARA5
transcripts (Fig. 2A). Additional studies showed that MSR1
knockdown had no reciprocal effect on the abundance of SR-
AII transcripts (data not shown). Although the MSR1 knockdown
Figure 3. Human macrophage scavenger receptor class A is required for TLR3 signaling triggered by HCV in hepatocytes. (A)
Immunoblot analysis of MSR1 expression in (top panels) Huh7.5-TLR3 and (bottom panels) PH5CH8 cells transduced with MSR1-specific (shMSR1) or
non-targeting control shRNA (shNT) lentiviruses. (B) Effect of shRNA-mediated MSR1 depletion on uptake of FITC-labeled poly(I:C) by Huh7.5-TLR3 or
PH5CH8 cells. Cells were incubated with 10 mg/ml FITC-labeled poly(I:C) for 8, 16 or 24 hrs before harvest. Cells were washed extensively before
fixation and analyzed by flow cytometry. Uptake of FITC-labeled poly(I:C) is expressed as fold-change in mean fluorescence intensity (MFI) compared
to mock-treated cells. Statistical comparisons between the MFI at 8 hrs vs. the time indicated were made by two-way ANOVA with Bonferroni
correction for multiple comparisons: * p#0.02, ** p#0.001. (C) Effect of shRNA-mediated MSR1 depletion on TLR3 signaling. IFN-b and PRD-II
promoter activation was induced by extracellular poly(I:C) in MSR1-depleted (left) Huh7.5-TLR3 and (right) PH5CH8 cells exposed to 50 mg/ml of high
molecular weight poly(I:C) for 6 hrs. Statistical comparisons in this and other panels in this figure were between the shNT and shMSR1-treated cells: *
p#0.02, ** p#0.001. (D) Quantitative RT-PCR analysis of ISG56 mRNA in MSR1-depleted cells treated with poly(I:C) as in panel C. (E) Immunoblots of
ISG15 expression in MSR1-depleted (left) Huh7.5-TLR3 and (right) PH5CH8 cells treated with poly(I:C) for 24 hrs. (F) Immunoblot of ISG15 in MSR1-
depleted Huh7.5-TLR3 cells exposed to synthetic HCV dsRNA 50 mg/ml for 24 hrs. (G) Quantitative RT-PCR analysis of ISG56 mRNA in Huh7.5-TLR3/
shMSR1 or Huh7.5-TLR3/shNT cells infected with HJ3-5 virus at an m.o.i. of 1 for 72 hrs. (H) Viral replication assessed by the fold-change in secreted
Gaussia luciferase in cultures of Huh7.5-TLR3/shMSR1 vs. Huh7.5-TLR3/shNT cells following infection with HJ3-5/GLuc2A virus. The level of Gaussia
luciferase activity at each time point was calculated relative to that at 6 hrs after infection, which was set at 1. Data are the mean 6 s.d. from three
independent experiments. The difference in GLuc expression by Huh7.5-TLR3/shMSR1 vs. Huh7.5-TLR3/shNT cells was significant by two-way ANOVA
(p=0.006). Bonferroni post-tests were used to estimate the significance of differences at individual time points: * p#0.02. (I) Quantitative RT-PCR
analysis of HCV RNA in Huh7.5-TLR3/shMSR1 vs. Huh7.5-TLR3/shNT cells 72 hrs after infection with HCV. RNA abundance in the Huh7.5-TLR3/shMSR1
was calculated relative to that in Huh7.5-TLR3/shNT, which was set at 100%. (J) Co-immunoprecipitation of HCV RNA with Flag-TLR3 in lysates of
Huh7.5-TLR3/shMSR1 (lanes 3, 4, and 6) and Huh7.5-TLR3/shNT cells (lanes 1, 2 and 5) infected with HJ3-5 virus 72 hrs previously.
Immunoprecipitation was with anti-Flag. See legend to Fig. 1E for additional details.
doi:10.1371/journal.ppat.1003345.g003
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indicated that time-dependent uptake of FITC-labeled high
molecular weight (HMW) poly(I:C), a surrogate for HCV dsRNA,
was functionally eliminated in MSR1-depleted cells compared to
control cells (Fig. 3B). The high degree of inhibition of poly(I:C)
uptake was surprising, given the rather modest degree of MSR1
depletion evident in either cell type (Fig. 3A). It suggests that a
threshold level of expression is required for efficient dsRNA
uptake, possibly because class A scavenger receptors function as
multimeric complexes. IFN-b and NF-kB-responsive PRDII
promoter activities were also decreased in MSR1-depleted cells
compared to control cells when stimulated by the addition of
poly(I:C) to the medium (Fig. 3C), as was poly(I:C) induction of
ISG56 (Fig. 3D) and ISG15 (Fig. 3E) expression. These results
indicate that MSR1 is required for poly(I:C) uptake and optimal
induction of TLR3-mediated signaling by poly(I:C) in human
hepatocytes.
Next, we examined whether MSR1 is required for the
recognition of HCV-specific dsRNA through TLR3. As with
poly(I:C), MSR1 depletion eliminated the induction of ISG15 or
ISG56 by synthetic HCV dsRNA added to the medium bathing
Huh7.5-TLR3 cells (Fig. 3F and G). We also demonstrated that
MSR1 functions in the induction of TLR3-mediated antiviral
responses to HCV infection by monitoring viral replication in
Huh7.5-TLR3/shNT cells and Huh7.5-TLR3/shMSR1 cells
following infection with HJ3-5/GLuc2A virus [33] that expresses
the secreted reporter protein, Gaussia princeps luciferase (GLuc).
Replication was assessed by measuring secreted GLuc activity and
by qRT-PCR analysis of intracellular HCV RNA abundance. Both
GLuc activity (Fig. 3H) and HCV RNA abundance (Fig. 3I) were
significantly increased in MSR1-depleted TLR3-expressing cells
compared to control cells transduced with shNT, suggesting at least
partial release from a TLR3-mediated antiviral response in these
cells.Consistent with a role for MSR1intransportingHCVRNAto
the endosome where it can engage TLR3, HCV RNA was no
longer detected in immunoprecipitates of TLR3 prepared from
lysates of infected, MSR1-depleted cells (Fig. 3J, lane 4 vs. lane 2).
To exclude the unlikely possibility that these results might in
some way reflect an off-target effect of shMSR1, we reconstituted
MSR1 expression in Huh7.5-TLR3/shMSR1 cells by ectopic
expression of Myc-tagged MSR1 using an expression vector
lacking the 59 untranslated RNA (UTR) segment of the
endogenous MSR1 mRNA targeted by shMSR1 (Fig. 4A). As
we anticipated, poly(I:C) stimulation of IFN-b promoter activity
was substantially restored by stable expression of Myc-MSR1 in
Huh7.5-TLR3/shMSR1 cells (‘‘Myc-MSR1 cells’’) (Fig. 4B). In
addition, HCV RNA replication levels were reduced in HCV-
infected Myc-MSR1 cells compared to Huh7.5-TLR3/shMSR1
cells (Fig. 4C). Co-immunoprecipitation experiments using an anti-
Myc antibody also demonstrated an association between Myc-
MSR1 and HCV RNA in HCV-infected Myc-MSR1 cells
(Fig. 4D, lane 3).
Collectively, the results shown in Figs. 3 and 4 demonstrate that
MSR1 plays an essential role in the transport of double-stranded
HCV RNA to TLR3, which engages this ligand in endosomes
[4,11,12] to initiate signaling triggered by HCV infection.
A positively-charged region within the collagen
superfamily domain of MSR1 is required for TLR3
signaling
The domain architecture of MSR1 (Fig. 5A) includes a
conserved collagen superfamily domain with approximately 20
Gly-X-Y repeats that are predicted to form a collagen-like, triple-
helical structure [34] (Fig. 5A). This domain is required for the
binding of acetylated LDL to the bovine homolog of MSR1 [29],
but its role in MSR1 recognition of dsRNA is unknown. We
postulated that a series of positively-charged residues located
within the carboxy terminus of the collagen superfamily domain,
between amino acids (a.a.) 325–338 of human MSR1, could
provide for interactions with the negatively-charged sugar-
phosphate backbone of dsRNA, and thus be important for
MSR1-mediated transport of dsRNA to TLR3. To test this
hypothesis, we constructed a series of Myc-MSR1 expression
vectors with deletion of a.a. 321–339 (Myc-MSR1/D321–339), or
Figure 4. Reconstitution of MSR1 expression in MSR1-depleted cells restores TLR3 signaling triggered by HCV. (A) Reconstitution of
MSR1 expression in Huh7.5-TLR3/shMSR1 cells. Myc-tagged MSR1 was stably expressed by retroviral transfer of a shMSR1-resistant vector (pCX4bsr/
Myc-MSR1). Lysates were immunoprecipitated with anti-Myc, then subjected to immunoblotting as described in Materials and Methods.
‘‘Vector’’=cells transduced with empty vector. (B) Restoration of poly(I:C) induction of IFN-b promoter activity by ectopically expressed Myc-MSR1 in
Huh7.5-TLR3/shMSR1 cells. Cells were co-transfected with pCX4bsr/Myc-MSR1 (vs. empty vector), pIFN-b-Luc and pRL-CMV (internal control reporter)
and cultured for 24 h, then treated with poly(I:C) (50 mg/ml) for 6 hrs prior to lysis and luciferase assay. Huh7.5-TLR3/shNT cells, transfected with
empty vector, were included as a positive control. (C) Quantitative RT-PCR analysis of HCV RNA in Huh7.5-TLR3/shMSR1 cells stably expressing Myc-
MSR1 (vs. empty vector) 72 hrs after infection with HJ3-5 virus at an m.o.i. of 1. (D) Co-immunoprecipitation of HCV RNA with Myc-MSR1 in lysates of
Huh7.5-TLR3/shMSR1 cells stably expressing Myc-MSR1 (lanes 3 and 6) vs. empty vector (lanes 2 and 5). Cells were infected with HJ3-5 virus (m.o.i.=1)
72 hrs prior to lysis. Immunoprecipitation was with anti-Myc, demonstrating association of HCV RNA with Myc-MSR1. See legend to Fig. 1E for further
details.
doi:10.1371/journal.ppat.1003345.g004
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charged residues: Arg
325, Lys
332, Lys
335 and Lys
338 (Fig. 5B). With
the exception of Lys
338, that is Glu in the chimpanzee (Pan
troglodytes), a positively-charged side chain is conserved at each of
these positions in MSR1 homologs from a wide variety of
mammalian species (Fig. 5A). Consistent with an essential role for
the carboxy terminus of the collagen superfamily domain in
dsRNA trafficking, transient expression of Myc-MSR1/D321–339
failed to rescue poly(I:C) induction of IFN-b promoter activity in
the MSR1-depleted Huh7.5-TLR3/shMSR1 cells (Fig. 5C, left
panel). While Ala substitutions at Lys
332, Lys
335 and Lys
338 (Myc-
MSR1/3KA) or at Arg
325 (Myc-MSr1/R325A) caused only a
modest reduction in the ability of the wt Myc-MSR1 to rescue
signaling (Fig. 5C, center and right panels), Ala substitutions at all
4 positions (Myc-MSR1/R3KA) resulted in a nearly complete loss
of the ability to rescue signaling in Huh7.5-TLR3/shMSR1 cells
exposed to poly(I:C) (Fig. 5C, right panel). The mutants were
expressed at high levels (Fig. 5D), and flow cytometry indicated
that the Myc-MSR1/R3KA and Myc-MSR1/D321-229 mutants
traffic to the cell surface (Fig. 5E). Thus, the loss of signaling
cannot be explained by the MSR1 mutants being improperly
processed, aberrantly degraded, or not transported to the cell
surface. The results are consistent with a loss of dsRNA-binding
capacity by Myc-MSR1/D321–339 and Myc-MSR1/R3KA, and
suggest that the positively-charged residues in the MSR1 collagen
superfamily domain are involved in dsRNA transport and required
for TLR3 signaling.
To confirm that these mutations do in fact ablate the ability of
MSR1 to bind HCV RNA replication intermediates, we assessed
the association of wt Myc-MSR1, Myc-MSR1/D321–339 and
Myc-MSR1/R3KA with HCV RNA in co-immunoprecipitation
experiments (Fig. 5F). HJ3-5 virus-infected Huh-7.5 cells were co-
cultured with MSR1-depleted PH5CH8/shMSR1 cells in which
stable expression of each of these Myc-MSR1 mutants (or empty
vector) had been established. Cell lysates were immunoprecipitat-
ed with anti-Myc antibody, and RNA extracted from the
immunoprecipitates assayed by HCV-specific RT-PCR. The
anti-Myc immunoprecipitate prepared from cells expressing wt
Myc-MSR1 was significantly enriched in HCV RNA (Fig. 5F, lane
2) compared to immunoprecipitates prepared from cells expressing
either the D321–339 or R3KA mutants (lanes 3 and 4), or empty
vector (lane 1). Collectively, these results reveal that conserved
positively-charged residues within the carboxy terminus of the
collagen superfamily domain of MSR1 are essential for TLR3-
mediated responses to dsRNA, and that they contribute to a
dsRNA-binding domain in MSR1.
MSR1 facilitates TLR3 recognition of HCV infection in
neighboring cells
Since infected Huh-7.5 cells served as the source of viral RNA
bound by Myc-MSR1 expressed within the PH5CH8/shMSR1
cells in the co-culture experiment shown in Fig. 5, these results
suggest that TLR3, through the dsRNA-scavenging functions of
MSR1, is capable of sensing the presence of HCV infection in
Figure 5. Poly(I:C) induced TLR3 signaling is dependent upon a conserved collagen superfamily domain in MSR1. (A) (top) Domain
architecture of the 451 a.a. human MSR1 protein showing the location of the collagen superfamily domain that contains multiple G-X-Y repeats that
form a triple helix [58]. (bottom) Alignment of human MSR1 with other mammalian MSR1 proteins near the C-terminus of the collagen domain,
showing multiple conserved basic residues. GenBank accession numbers are shown for each. ‘‘Macscav’’=conserved macrophage scavenger receptor
domain; ‘‘SRCR’’=Cys-rich scavenger receptor superfamily domain. (B) Myc-MSR1 mutants constructed within the pCX4bsr/Myc-MSR1 plasmid. (C)
Poly(I:C) stimulated IFN-b promoter activity in MSR1-depleted Huh7.5 TLR3/shMSR1 cells transiently expressing wt or mutant Myc-MSR1: (left) Myc-
MSR1/D321–339 (deletion of underlined sequence in panel A), (center) Myc-MSR1/3KA, or (right) Myc-MSR1/R325A and Muc-MSR1/R3KA. Cells were
co-transfected with Myc-MSR1 expression vectors, pIFN-b-Luc and pRL-CMV (internal control), cultured for 24 h, then treated with poly(I:C) (50 mg/ml)
for 6 hrs before to lysis and luciferase assay. (D) Immunoblots showing expression of wt Myc-MSR1 and related mutants in PH5CH8/shMSR1 cells.
Lysates were precipitated with anti-Myc antibody prior to anti-Myc immunoblot. (E) Flow cytometry histograms showing expression of Myc-MSR1
(wt) and indicated mutants on the surface of PH5CH8 cells (green lines). Purple curves indicate cell-surface staining with isotype immunoglobulins.
‘‘FL2-H’’=fluorescent intensity. (F) Co-immunoprecipitation analysis of the association of HCV RNA with wt versus mutant Myc-MSR1 proteins in
PH5CH8/shMSR1 cells co-cultured with Huh7.5 cells infected with HJ3-5 virus (m.o.i.=1) for 72 hrs. RNA was extracted anti-Myc precipitates from
lysates of co-cultures of infected Huh7.5 cells and PH5CH8/shMSR1 cells stably transduced with empty vector (lane 1 and 5), wt Myc-MSR1 (lane 2 and
6), D321–339 (lane 3 and 7), or R3KA (lane 4 and 8). See legend to Fig. 1E for further details.
doi:10.1371/journal.ppat.1003345.g005
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demonstrating TLR3 sensing of HCV infection by hepatocytes [4]
have not distinguished between the sensing of replication
intermediates produced within the same cell versus those released
into the extracellular milieu from neighboring infected cells.
To further explore this phenomenon, we generated cell lines
that could serve as either infected ‘‘inducer’’ cells or TLR3-
competent ‘‘sensor’’ cells in co-culture experiments (Fig. 6A). The
inducer cells were Huh-7.5 cells infected with HJ3-5/5A-YFP
virus, which expresses a fusion of the NS5A protein with YFP [35],
thereby allowing infected cells to be identified by fluorescence
microscopy. These inducer cells are not competent for either RIG-
I or TLR3 signaling [17,26]. The sensor cells were 293FT/IFN-b-
mCherry cells, human embryonic kidney cells expressing endog-
enous TLR3 and the fluorescent reporter protein, mCherry, under
the control of the IFN-b promoter. These 293FT/IFN-b-mCherry
Figure 6. TLR3 expressed in 293-hTLR3 cells senses HCV replication in adjacent human hepatocytes. (A) Experimental design, showing
co-culture of HCV-nonpermissive, TLR3-competent 293FT/IFN-b-mCherry cells expressing mCherry under control of the IFN-b promoter with Huh-7.5
cells that are HCV permissive and TLR3 incompetent. Cells were infected with HJ3-5/5A-YFP virus that expresses YFP as a fusion with NS5A. (B)
Immunofluorescence microscopy demonstrating induction of mCherry expression in 293FT/IFN-b-mCherry + Huh-7.5 cell co-cultures upon
stimulation with poly(I:C) or infection with HJ3-5/NS5A-YFP virus. HCV replication was visualized by YFP expression and present in cells adjacent to
those expressing mCherry in the two-color merged images at the far right. Nuclei were visualized by DAPI counterstain. (C) siRNA-mediated depletion
of TLR3 significantly reduces poly-(I:C)-induced activation of the IFN-b promoter in 293FT/IFN-b-mCherry cells. (left) Fold-change in luciferase activity
induced by extracellular poly-(I:C) in 293FT/IFN-b-mCherry cells transfected with TLR3-specific (siTLR3) or control (siCont) siRNAs. The cells were
transduced with an IFN-b-Luc reporter plasmid. * p#0.02. (right) qRT-PCR detection of TLR3-specific mRNA in cells transfected with the siTLR3 or
siCont siRNAs. * p#0.02. (D) Poly-(I:C)-induced expression of mCherry in 293FT/IFN-b-mCherry cells is ablated by prior transfection with TLR3-specific
siRNA. (E) siRNA-mediated depletion of TLR3 eliminates mCherry expression by 293FT/IFN-b-mCherry cells placed in co-culture with HCV-infected
Huh-7.5 cells. 293FT/IFN-b-mCherry cells were transfected with siTLR3 or siCont siRNAs 3 days prior to being placed in co-culture with Huh-7.5 cells
infected with genotype 2a JFH-1 virus. (F) Experimental design, showing Huh7.5-TLR3 cells co-cultured with Huh7.5 cells supporting replication of a
genome-length genotype 1a HCV RNA replicon. (G) Co-immunoprecipitation analysis of the association of HCV RNA with Flag-TLR3 in co-cultures of
Huh7.5-TLR3 and HCV replicon cells (panel F) after treatment with bafilomycin (1.0 nM, lanes 2 and 5) or chloroquine (5.0 mM, lanes 3 and 6) for
72 hrs. RNA was extracted from anti-Flag precipitates prepared from lysates of the co-cultured cells and subjected to HCV-specific RT-PCR. See legend
to Fig. 1E for further details.
doi:10.1371/journal.ppat.1003345.g006
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(Fig. 2B, lower panel). Importantly, they are nonpermissive for
HCV replication. As expected, co-culture of mock-infected Huh-
7.5 cells and the 293FT/IFN-b-mCherry cells resulted in no
detectable YFP or mCherry signal (Fig. 6B, left set of panels).
However, mCherry expression could be induced by the addition of
poly(I:C) to the medium bathing these co-cultured cells (Fig. 6B,
second set of panels from the left). Infection of the co-cultured cells
with HJ3-5/5A-YFP virus also resulted in the induction of
mCherry in the 293FT/IFN-b-mCherry cells (Fig. 6B, right
panels and merged image). The cells expressing mCherry lacked
detectable YFP fluorescence, confirming that they were not
infected. Similar results were obtained with 293/hTLR3-IFN-b-
mCherry cells, which are engineered to overexpress TLR3, and
also express mCherry under control of the IFN-b promoter
(Supplementary Fig. S3). Prior transfection of 293FT/IFN-b-
mCherry cells with siRNA targeting TLR3 significantly reduced
poly-(I:C)-induced IFN-b promoter activity (Fig. 6C) and mCherry
expression (Fig. 6D), confirming that dsRNA sensing by TLR3
activates the IFN-b promoter (and mCherry expression) in these
cells. Similarly, siRNA-mediated depletion of TLR3 in 293FT/
IFN-b-mCherry cells largely eliminated mCherry expression when
the cells were co-cultured with HCV-infected Huh-7.5 cells
(Fig. 6E). These results indicate that TLR3 is capable of sensing
HCV infection in neighboring cells, presumably via MSR1-
mediated transport of extracellular dsRNA to the endosome where
TLR3 is expressed.
In separate experiments, HCV RNA co-immunoprecipitated
with Flag-TLR3 when Huh7-TLR3 cells were co-cultured with
Huh-7.5 cells containing an HCV replicon RNA (Fig. 6F and G),
providing additional evidence that HCV RNA produced in
adjacent cells may serve as ligand for TLR3. Consistent with the
fact that TLR3 signaling is initiated only in the endosome, not at
the cell surface [12], and more specifically that acidification of the
endosome is required for TLR3 signaling in Huh7.5-TLR3 cells
[4], treatment of these co-cultured cells with bafilomycin (1 nM) or
chloroquine (5 mM) substantially reduced the amount of HCV
RNA that co-immunoprecipitated with TLR3 (Fig. 6G).
To demonstrate that TLR3 signaling induced within cells
adjacent to those infected results in functional antiviral activity, as
well as to formally demonstrate a role for MSR1 in this process, we
replaced the 293 sensor cells with PH5CH8 cells (Fig. 7A, left).
These T antigen-transformed, TLR3-competent human hepato-
cytes [17] are nonpermissive for HCV infection due in part to a
lack of expression of miR-122 (D. Yamane and S.M. Lemon,
unpublished data), an essential host factor for HCV replication
[36]. We infected Huh-7.5 cells with HJ3-5/GLuc2A virus, and
6 hrs later split the culture to create co-cultures of HCV-infected
Figure 7. MSR1-dependent TLR3 sensing of HCV infection in neighboring cells restricts viral replication. (A)( left) Design of co-culture
experiments in which HCV-nonpermissive, but TLR3-competent, PH5CH8 cells were co-cultured with HCV-permissive, but RIG-I and TLR3-
incompetent, Huh-7.5 cells infected with HJ3-5/GLuc2A, a reporter virus that expresses GLuc as a component of its polyprotein. Huh-7.5 cells were
infected with virus for 6 hrs prior to being split and added to either MSR1-depleted PH5CH8/shMSR1 or control PH5CH8/shNT cells (Fig. 3A) at a ratio
of 1:2 to establish co-cultures. (right) Gaussia luciferase activity in supernatant fluids of HJ3-5/GLuc2A-infected co-cultures. Data shown are means 6
s.d. from 3 replicate cultures and are representative of repeat, independent experiments. The difference in GLuc expression from shMSR1- vs. shNT-
treated cells was significant by two-way ANOVA (p,0.0001). (B)( left) Co-cultures of PH5CH8/shMSRI (or control PH5CH8/shNT) cells and HJ3-5/
GLuc2A virus-infected Huh-7.5 cells in which the cell types are separated by a semi-permeable membrane (Transwell system). (right) Gaussia luciferase
activity in supernatant fluids of HJ3-5/GLuc2A virus-infected Huh-7.5 cells separated from the PH5CH8 cells by a semi-permeable membrane. Data
shown are means 6 s.d. from 3 replicate cultures. Unlike Huh-7.5 cells cultured in close continuity with PH5CH8 cells (panel A), there is no restriction
to HCV replication when the cell types are separated by a permeable membrane. The difference in GLuc expression from shMSR1- vs. shNT-treated
cells was not significant by two-way ANOVA (p=0.20).
doi:10.1371/journal.ppat.1003345.g007
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PH5CH8 cells transduced with the non-targeting control, shNT
(Fig. 2A). HCV replication in the co-cultures was monitored over
time by measuring GLuc activity in the culture supernatant fluids
(Fig. 7A, right). Our expectation was that TLR3-dependent
signaling should be triggered in PH5CH8 cells when placed in co-
culture with infected Huh-7.5 cells (that lack both TLR3 and RIG-
I-mediated signaling) [17,26], and that this would result in an
antiviral response capable of restricting HCV replication in the
Huh-7.5 cells through paracrine signaling. This was precisely what
we observed. Secreted GLuc activity, which is proportionate to the
replication of the reporter virus, was consistently reduced by 50%
or more when the infected cells were co-cultured with PH5CH8/
shNT versus PH5CH8/shMSR1 cells (Fig. 7A, right). Since some
laboratory strains of HCV induce apoptosis in Huh-7.5 cells [37],
we determined the proportion of Huh-7.5 cells undergoing
apoptosis after 4 days of infection with HJ3-5/GLuc2A virus.
These studies demonstrated no increase in the proportion of Huh-
7.5 cells expressing detectable cleaved caspase 3 protein or
demonstrating TUNEL fluorescence (Supplementary Fig. S4).
Thus, apoptosis of infected cells is not required for sensing of
infection by adjacent, TLR3 competent hepatocytes.
To gain further insight into the MSR1-mediated restriction of
HCV replication in neighboring cells, we assessed the replication
of HJ3-5/GLuc2A virus in Huh-7.5 cells that were separated
from PH5CH8/shMSR1 (or PH5CH8/shNT) cells by a
permeable membrane in Transwell culture dishes (Fig. 7B, left).
Under these conditions, MSR1 depletion in the TLR3-compe-
tent PH5CH8 cells had no impact on the rate of HCV
replication in the Huh-7.5 cells (Fig. 7B, right). These results
indicate a need for close positioning and possibly direct cell-cell
contact for MSR1-dependent sensing of infection in neighboring
hepatocytes. Despite the restriction imposed on virus replication
in Huh-7.5 cells by PH5CH8 cells, we were unable to detect
IFN-b in media from the direct co-cultures (Fig. 7A) using an
ELISA with a level of detection of approximately 10 pg/ml.
Collectively, these data show that the antiviral response induced
by MSR1-dependent recognition of viral RNA produced in
neighboring cells is functional and restricts replication in the
infected cell, but that this effect is limited in magnitude and
highly localized.
Discussion
The class A scavenger receptors comprise a diverse family of 5
homotrimeric, single-pass type II membrane proteins that bind to
and facilitate the cellular import of a broad range of ligands,
including acetylated LDL, bacterial cell wall constituents, and both
ssRNA and dsRNA [20,22,32]. While their expression has been
considered previously to be restricted to cells of myeloid origin,
primarily macrophages (hence the name, ‘‘macrophage scavenger
receptor’’), more recent data suggest that members of this receptor
family are expressed more ubiquitously and are present on the
surface of a variety of cell types [22]. The various members of the
family differ in length, domain architecture, ligand specificity and
function, but have been recognized increasingly to play important
roles in innate immune signaling. Several class A scavenger
receptors, in particular MARCO (or SCARA2), and SCARA4
(collectin-12), function in innate immune recognition of bacterial
infections, while MSR1 (SCARA1, SR-AI, or CD204) has been
shown recently to contribute to antiviral responses evoked by
extracellular dsRNA [reviewed in 22]. Mice with genetic
deficiency of the homolog of MSR1 demonstrate increased
susceptibility to infection with herpes simplex virus [38], while
MSR1 is required for induction of TLR3-mediated signaling in
monocytes exposed to human cytomegalovirus [39].
DeWitte-Orr et al. [22] have recently suggested that the family
of class A scavenger receptors represent the major receptors for
dsRNA on the surface of fibroblasts, and that they act in a
cooperative fashion to deliver dsRNA to both endosomal TLR3 as
well as RIG-I-like helicases expressed within the cytoplasm of
these cells. The data we present here provide additional support
for this general conclusion, but show with greater specificity that
MSR1 is the dominant surface receptor for dsRNA in human
hepatocyte-derived cell lines. While DeWitte-Orr et al. [22] found
that selective knockdown of any one member of the class A
scavenger receptor family (including MSR1) had no effect on
dsRNA uptake or poly(I:C)-stimulated ISG expression, we found
that a relatively low efficiency knockdown of MSR1 only
profoundly disrupts the ability of extracellular poly(I:C) to
stimulate IFN-b promoter activity and ISG expression in both
Huh7.5-TLR3 cells and PH5CH8 cells (Fig. 3). In all of our
studies, these two cell lines behaved similarly. This is important, as
Huh-7 cells, from which Huh7.5-TLR3 cells are derived, originate
from an hepatocellular carcinoma. In contrast, the PH5CH8 cell
line was established by transformation of non-neoplastic human
hepatocytes with the large T antigen of simian virus 40 [30]. These
cells, like primary hepatocytes, express TLR3 endogenously and
are stimulated to produce an IFN response when exposed to
extracellular poly(I:C) [4]. Although hepatocytes express several
members of the class A scavenger receptor family (Fig. 2), the fact
that depletion of MSR1 alone disrupts this response suggests that
MSR1 is uniquely required for the uptake and transport of
extracellular dsRNA so that it may be sensed by TLR3 in these
cells.
In addition to showing that MSR1 expression is required for
TLR3-mediated responses to poly(I:C) or infectious challenge with
HCV in hepatocyte-derived cells, our data show that MSR1 is
physically associated with viral RNA, even when it is produced by
ongoing RNA replication in neighboring cells (Fig. 6F and G), and
that MSR1 expression is required for TLR3 to bind HCV RNA as
ligand (Fig. 3J). We show directly that MSR1 forms a complex with
HCV RNA (Fig. 4D), and identify several conserved basic residues
within the carboxyl terminus of the collagen superfamily domain
that are required for dsRNA uptake by MSR1 and TLR3-mediated
signaling in hepatocytes (Fig. 5). There are three alternatively
spliced isoforms of MSR1 in humans, only two of which (type I and
type II) are expressed on the plasma membrane and facilitate
endocytosis of ligands [40]. While the type I isoform is 451 a.a. in
length, type II MSR1 is only 358 a.a. However, the amino-terminal
343 residues of these isoforms are identical in sequence, and both
isoforms contain the collagen superfamily domain and RNA-
binding subdomain we have identified between residues 321–339.
Importantly, although we found a low abundance of isoform II
transcripts in Huh-7.5 cells (Fig. 2B), only isoform I (49.7 kDa) was
detected in immunoblots of Huh7.5-TLR3 and PH5CH8 cells, and
not isoform II (39.6 kDa) or III (42.9 kDA).
The positively-charged carboxy-terminal region of the collagen
superfamily domain is required for the association of MSR1 with
acetylated LDL [41]. Its sequence is highly conserved among
mammalian species with the exception, interestingly, of the
chimpanzee (Fig. 5A). In addition to the 4 positively charged
residues (Arg
325, Lys
332, Lys
335 and Lys
338) present in human
MSR1, this subdomain contains a conserved negatively-charged
residue (Glu
337). Previous studies suggest this domain assumes a
collagen-like, triple-helical conformation at pH.4.5, stabilized in
part by electrostatic interactions of Glu
337 with one of the
conserved Lys residues [34]. This leaves the remaining unpaired
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ligands, including association with the negatively-charged sugar-
phosphate backbone of dsRNA. MSR1 bound to acetylated LDL
is internalized through receptor-mediated endocytosis, dissociating
under acidic conditions within the endosome due to the loss of ion
pairing between Glu
337 and the conserved Lys residues within the
collagen-like domain [34,42]. We presume that MSR1 functions
similarly in the uptake of dsRNA from the extracellular milieu.
This may explain why inhibitors of endosomal acidification block
TLR3-mediated antiviral responses, as we have shown previously
for Huh7.5-TLR3 cells [4], and inhibit the co-immunoprecipita-
tion of HCV RNA with TLR3 in infected Huh7.5-TLR3 cells
(Fig. 6D).
An important observation to emerge from these studies is that
hepatocytes are capable of sensing HCV infection in adjacent cells,
and that MSR1 mediates this response by acting as a carrier of
replication intermediates (presumably dsRNA) from the extracel-
lular milieu to endosomally expressed TLR in uninfected cells.
While it is often assumed that TLR3 expressed within parenchy-
mal cells such as hepatocytes may sense virus infection in
neighboring cells, we demonstrated this formally in co-cultures
of HCV-nonpermissive, TLR3-competent cells (293FT or
PH5CH8 cells) and infected Huh-7.5 cells that are deficient in
both TLR3 and RIG-I sensing of HCV infection [17,26] (Figs. 6
and 7). We show that this results in a localized antiviral effect,
restricting the replication of virus in the co-cultured cells, and that
it is dependent upon MSR1 expression in the uninfected cells since
it can be blocked by RNAi-mediated depletion of MSR1 (Fig. 7B).
These observations have important implications for the
pathogenesis of chronic hepatitis C. For reasons that are unclear,
only a small fraction of hepatocytes appear to be infected with
HCV in these patients [25]. Two-photon immunofluorescence
microscopy of frozen sections of infected human liver tissue has
revealed clusters of infected cells, identified either by detection of
HCV-specific antigens or dsRNA replication intermediates,
typically surrounded by greater numbers of uninfected cells [25].
The presence of these discreet foci of infection suggests that the
spread of virus is actively restricted within the liver. The data we
present here suggest a model in which TLR3 mediates the
establishment of an antiviral state in uninfected cells adjacent to
those that are infected in a process that is facilitated by the
dsRNA-scavenging actions of MSR1. Such a model also explains
why HCV infection induces ISG expression within the liver,
despite its ability to disrupt both RIG-I and TLR3 responses by
NS3/4A-mediated cleavage of the RIG-I adaptor molecule,
MAVS [15,16], and the TLR3 adaptor molecule, TICAM-1
(TRIF), within infected cells [4,18]. TLR3 sensing of HCV
infection is not likely to be restricted to neighboring hepatocytes,
as we have demonstrated here, but may also occur in tissue-
resident macrophages (Kupffer cells) or monocyte-macrophages
recruited to the site of infection. TLR7 expressed within
plasmacytoid dendritic cells (pDCs) may also sense infection in
other cells [43]. While less robust on a single cell level than in these
‘‘professional’’ innate immune cells, TLR3-mediated antiviral
responses in the very large number of parenchymal hepatocytes
exposed to HCV may nonetheless make a substantial contribution
overall to the induction of intrahepatic ISG responses observed in
patients with chronic hepatitis C [24].
Materials and Methods
Cells
Huh-7.5 cells [44] were a gift from Charles Rice (Rockefeller
University, NY). Huh-7.5 cells engineered to express either TLR3
or the TLR3 mutants DTIR, H539E or N541A have been
described previously [4]. 293FT cells, human embryonic kidney
cells transformed with SV40 T antigen, were purchased from
Invitrogen (Carlsbad, CA). 293-hTLR3 cells (engineered to over-
express human TLR3) were purchased from InvivoGen. The non-
neoplastic T-antigen immortalized hepatocyte cell line PH5CH8
has been described previously [30,45]. These cells were cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented
with 10% fetal bovine serum. Blasticidin (2 mg/ml) or G418
(0.3 mg/ml) was added for the selection of cells exogenously
expressing TLR3-Flag, Myc-MSR1 and related mutants. G418
(0.3 mg/ml) was added for the selection of HCV RNA replicon
colonies.
Virus
Two strains of HCV were used in these studies: the genotype 2a
JFH-1 virus [46], and HJ3-5, a cell culture-adapted genotype 1a/
2a chimeric virus containing the structural proteins of the
genotype 1a H77 virus placed within the background of JFH-1
virus [47,48]. HJ3-5/GLuc2A is a derivative of HJ3-5 containing
the Gaussia princeps luciferase (GLuc) coding sequence fused to the
foot-and-mouth disease virus (FMDV) 2A sequence and inserted
between p7 and NS2 of HJ3-5 virus [49]. Cells were infected at an
m.o.i. of 1. GLuc activity in supernatants was measured by BioLux
Gaussia Luciferase Assay Kit (New England Biolabs, Ipswich, MA)
using a Synergy2 multi-mode microplate reader (BioTek,
Winooski, VT). HJ3-5/5A-YFP is another derivative of HJ3-5
containing yellow fluorescent protein (YFP) coding sequence fused
to NS5A sequence [35].
Plasmids
ptat2ANeoH77S [27] contains the tat protein, 15 amino acids of
the FMDV 2A protein and neomycin phosphotransferase (Neo
R)
downstream of HCV internal ribosome entry site (IRES) and the
full-length H77S (genotype 1a) polyprotein-coding sequence
downstream of the encephalomyocarditis virus IRES. pIFN-b-
Luc and pPRDII-Luc have been described previously [50,51].
pIFN-b-mCherry, which expresses the mCherry fluorescent
protein under transcriptional control of the IFN-b promoter,
was constructed by replacing the firefly luciferase sequence in
pIFN-b-Luc with the mCherry sequence. pJFH1-T3 was con-
structed by introducing a T3 promoter downstream of the HCV
39UTR in pJFH1 [46].
pCX4neo/Myc-MSR1 and pCX4bsr/Myc-MSR1 were con-
structed from the retroviral vectors pCX4neo and pCX4br [52],
which contain the resistance gene for neomycin and blasticidin
respectively. A DNA fragment encoding MSR1 (accession
no. NM_138715) was amplified from cDNA obtained from
Huh-7 cell DNA by PCR using PrimeSTAR HS DNA polymerase
(TaKaRa) and primers with SphI (forward) and the NotI (reverse)
recognition sites that were designed to enable expression of the
MSR1 ORF. The DNA was cloned into the SphI and NotI sites of
pCX4neo/Myc and pCX4bsr/Myc, fusing MSR1 sequence to
Myc. Mutations within the Myc-MSR1 sequence were subse-
quently constructed by PCR mutagenesis as previously described
[53]. The nucleotide sequences of these vectors were confirmed by
DNA sequencing. Cells stably expressing Myc-MSR1 were
prepared as previously described [54].
Synthetic HCV dsRNA
pJFH1-T3 was linearized by either XbaIo rEcoRI to provide
templates for synthesis of positive- or negative-stranded HCV
RNA using T7 or T3 MEGAscript kits (Ambion, Austin, TX).
Positive- and negative-stranded HCV RNA products were
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followed by slow cooling to room temperature. The annealed
product was assayed for sensitivity to S1 nuclease (Promega,
Madison, WI) to confirm that it was double-stranded.
Poly(I:C)
High molecular weight (HMW) poly(I:C) was purchased from
Invivogen (San Diego, CA). Cells were exposed to a concentration
of 50 mg/ml for 6 hrs unless otherwise stated. Fluorescein-labeled
HMW poly(I:C) (Invivogen) was used to monitor dsRNA uptake
by cells. Cells were mock-exposed or exposed to 10 mg/ml
fluorescein-labeled poly (I:C) for 8, 16 or 24 hrs, then harvested
by trypsinization, washed twice in phosphate buffered saline (PBS)
and fixed for 15 minutes in 4% paraformaldehyde. After
additional washing in 16 PBS, the fluorescence intensity of cell
populations was analyzed using a Beckman Coulter (Dako) CyAn
flow cytometer.
Promoter reporter assays
IFN-b and NF-kB-dependent promoter activities were assayed
using firefly luciferase reporters, pIFN-b-Luc or pPRDII-Luc, with
the reporter plasmid pRL-CMV used as an internal control for
transfection efficiency as previously described [55]. A Turner
Designs Luminometer Model TD-20/20 (Promega, Madison, WI)
was used to measure luciferase activity. Data shown represent
means 6 s.d. from three independent transfection experiments.
Immunoblot analysis
Preparation of cell lysates and SDS-PAGE were carried out as
previously described [56]. Total protein was transferred to
Immobilon-psq PVDF membranes (Millipore, Billerica, MA) using
a Trans-blot SD semi-dry transfer cell (Bio-Rad, Hercules, CA).
Primary antibodies included anti-Flag (M2; Sigma, St Louis, MO),
anti-Myc (9B11; Cell Signaling, Danvers, MA), anti-ISG15 (H-
150; Santa Cruz Biotechnology Inc., Santa Cruz, CA), anti-MSR1
(H-190; Santa Cruz Biotechnology Inc.), and anti-b-actin antibody
(AC-15; Sigma). Secondary antibodies were IRDye-conjugated
anti-mouse IgG and anti-rabbit IgG (LI-COR Biosciences,
Lincoln, NE). Immunocomplexes were detected with an Odyssey
infrared imaging system (LI-COR Biosciences).
Quantitative RT-PCR analysis
Total cellular RNA was isolated using the RNeasy mini kit
(Qiagen, Valencia, CA). The iScript one-step RT-PCR kit with
SYBR Green and CFX96 real-time system (Bio-Rad) were used to
quantify the abundance of IFN-b, ISG56, GAPDH mRNA or
HCV RNA. We used the following forward and reverse primer
sets: IFN-b,5 9-GTGCCTGGACCATAGTCAGAGTGG-39 (for-
ward), 59-TGTCCAGTCCCAGAGGCACAGG-39 (reverse);
ISG56, AAGCTTGAGCCTCCTTGGGTTCGT-39 (forward),
59-TCAAAGTCAGCAGCCAGTCTCAGG-39 (reverse); GAPDH
[53], HCV, 59-CATGGCGTTAGTATGAGTGTCGT-39 (for-
ward), 59-CCCTATCAGGCAGTACCACAA-39 (reverse). IFN-b,
ISG56 and HCV RNAs were normalized to GAPDH mRNA.
Results shown represent means 6 s.d. from three independent
experiments.
Co-immunoprecipitation of Flag-TLR3 or Myc-MSR1 with
HCV RNA
Total cell lysates were prepared using lysis buffer (PBS
containing 0.2% Triton X-100, RNase inhibitor and protease
inhibitor cocktail), followed by immunoprecipitation with anti-Flag
or anti-Myc antibodies using protein G sepharose (GE healthcare).
RNAs were extracted from the immunoprecipitates using Trizol
(Invitrogen), and assayed for HCV RNA by RT-PCR using the
Superscript III One-step RT-PCR system (Invitrogen) followed by
agarose gel electrophoresis.
MSR1-depleted cells and Myc-MSR1 expression
Short hairpin RNA (shRNA) targeting MSR1 (shMSR1, 59-
GCATTGATGAGAGTGCTATTG-39) or non-targeting control
shRNA (Sigma; Mission shRNA SHC-002) were introduced into
Huh7.5-TLR3 or PH5CH8 cells by lentiviral transfer. MSR1-
depleted Huh7.5-TLR3/shMSR1 and PH5CH8/shMSR1 and
related control cells, Huh7.5-TLR3/shNT or PH5CH8/shNT
cells, were selected by addition of puromycin (5 mg/ml) to the cell
culture medium. MSR1 expression was reconstituted in MSR1-
depleted cells by retroviral transfer of the Myc-MSR1 sequence in
pCX4neo Myc-MSR1, which lacks the shMSR1 target sequence
within the 59UTR of MSR1 mRNA [57]. Cells stably expressing
Myc-MSR1 were selected by growth in G418 (0.3 mg/ml).
For analysis of the RNA-binding domain in MSR1, pCX4neo-
Myc-MSR1 was subjected to PCR-based mutagenesis using
standard methods, with the sequence of the manipulated regions
of the plasmid confirmed by DNA sequencing. Cell surface
expression of MSR1 and related mutants was analyzed by flow
cytometry. MSR1 has a transmembrane domain between aa 51–
73, with its carboxyl terminus exposed to the extracellular
environment. For detection of MSR1 on the cell surface, non-
permeabilized cells were fixed with 2% paraformaldehyde
followed by incubation with anti-MSR1 antibody (Santacruz, H-
190) for 1 h at room temperature. Cells were washed three times
with PBS, and incubated with R-phycoerythrin-conjugated anti-
rabbit IgG secondary antibody (Jackson ImmunoResearch) for
30 min at room temperature. Fluorescent intensity of cells was
determined using a FACScan (Becton Dickinson) flow cytometer.
Measurements of apoptosis in infected cells
Huh-7.5 cells were infected with HJ3-5/GLuc2A virus at an
m.o.i. of 0.03, or mock-infected, and cultured for 4 days. As a
positive control, cells were treated with 1 mM staurosporine for
6 hrs. Cells were harvested by trypsinization, washed twice in PBS
and fixed in 4% paraformaldehyde, then stained for cleaved
caspase 3 and HCV core protein as described previously [37].
DNA fragmentation was analyzed by terminal deoxynucleotidyl-
transferase-mediated dUTP-biotin nick end-labeling (TUNEL)
system (Promega, Madison, WI). Positive cells were quantified by
flow cytometry as described previously [37].
Statistical methods
Statistical comparisons were carried out using Student’s T test
unless otherwise noted. Calculations were made with Excel 2008 for
Mac (Microsoft) or Prism V for Mac OS X (GraphPad Software).
Supporting Information
Figure S1 Replicon colony formation assay demon-
strates that TLR3 expression restricts HCV replication.
Ten mg RNA, synthesized in vitro from linearized ptat2AneoH77S
DNA using a T7 MEGAscript kit (Ambion), were electroporated
into Huh7.5-TLR3, -DTIR, -H539E or -N541A cells in a 4-mm
cuvette by pulsing once at 400 V, 250 mF, and infinite V in a
BioRad Gene Pulser Xcell apparatus. The cells were then cultured
in G418 (0.3 mg/ml) for 3 weeks, and surviving cell colonies
stained with Coomassie brilliant blue (0.06% in 50% methanol-
10% acetic acid).
(TIF)
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lar weight poly(I:C). (A) To determine whether TLR3
discriminates between dsRNA of different lengths corresponding
to the size of viral genomes, we studied two dsRNA surrogates, low-
molecular weight (LMW) and high-molecular weight (HMW)
poly(I:C), that are between 0.2–1.0 and 1.5–8 kilobase pairs,
respectively. (B) Both LMW and HMW poly(I:C) stimulated IFN-b
promoter activity in a dose-dependent manner when added to the
medium bathing (left) Huh-7.5 cells engineered to express wt TLR3
(Huh7.5-TLR3 cells), but not (right) Huh7.5-DTIR cellsthat express
a defective TLR3 lacking the TIR domain and thus incapable of
signaling. Importantly, however,HMW poly(I:C) was300-foldmore
active than LMW poly(I:C) on a molar basis in stimulating IFN-b
promoter activity. (C) This was reflected in significantly greater
induction of ISG56 mRNA expression byHMW vs. LMW poly(I:C)
in Huh7.5-TLR3 cells or PH5CH8 cells that naturally express
TLR3. (D) At comparable concentrations, HMW poly(I:C) was also
more active than LMW poly(I:C) in stimulating ISG15 protein
expression in Huh7.5-TLR3 cells. Note the absence of ISG15
expression induced by either poly(I:C) in Huh7.5-H539E cells that
express an inactive TLR3 mutant that is defective in dsRNA
binding. (E) Similar differences in poly(I:C) induction of ISG15
protein expression were observed in PH5CH8 cells. Note that
ISG15 expression was reduced by shRNA knockdown of TLR3 in
these cells. Collectively, these results suggest that very lengthy
dsRNA, such as viral replication intermediates, are more powerful
inducers of TLR3-mediated antiviral responses than dsRNAs under
1 kb in length. While the mechanistic basis of this is uncertain, one
possibility is that the greater signaling strength derives from
progressive recruitment of multiple TLR3 ectodomains aligned
along a single dsRNA molecule.
(TIF)
Figure S3 Induction of IFN-b promoter activity in 293-
hTLR3/IFN-b-mCherry cells co-cultured with HCV-in-
fected Huh-7.5 cells. (A) Human 293-hTLR3/IFN-b-mCherry
cells transduced to overexpress TLR3 and the IFN-b-mCherry
reporter were co-cultured with infected or uninfected Huh-7.5 cells
using the same general experimental design as in the experiment
shown in Fig. 6A in the main manuscript. (B) Immunofluorescence
microscopy demonstrating induction of mCherry expression in 293-
hTLR3/IFN-b-mCherry + Huh-7.5 cell co-cultures upon stimula-
tion with poly(I:C) or infection with HJ3-5/NS5A-YFP virus. HCV
replication was visualized by YFP expression and is observed in cells
adjacent to those expressing mCherry in the two-color merged
images at the bottom. Nuclei were visualized by DAPI counterstain.
(TIF)
Figure S4 Absence of apoptosis in HJ3-5/GLuc2A-in-
fected cells. Analysis of cleaved caspase 3 and HCV core protein
(top row) and DNA fragmentation by TUNEL assay (bottom row)
in Huh-7.5 cells at 4 d following mock infection or infection with
HJ3-5/GLuc2A virus at a m.o.i. of 0.03. Cells treated with 1 mM
staurosporine for 3 hrs are shown as a positive control for
apoptosis induction.
(TIF)
Acknowledgments
The authors are grateful to Zongdi Feng for helpful advice and review of
the manuscript, and to Cindy Hensley for expert technical assistance.
Author Contributions
Conceived and designed the experiments: HD DY CW DRM FH SML.
Performed the experiments: HD DY DRM FH. Analyzed the data: HD
DY DRM CW SML. Contributed reagents/materials/analysis tools: NK.
Wrote the paper: HD DRM SML.
References
1. Lemon SM, Walker C, Alter MJ, Yi M (2007) Hepatitis C viruses. In: Knipe
DM, Howley PM, Griffin DE, Martin MA, Lamb RA, et al., editors. Fields
Virology, 5th Ed. Philadelphia: Lippincott Williams & Wilkins. pp. 1253–
1304.
2. Lemon SM (2010) Induction and evasion of innate antiviral responses by
hepatitis C virus. J Biol Chem 285: 22741–22747.
3. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004)
The RNA helicase RIG-I has an essential function in double-stranded RNA-
induced innate antiviral responses. Nat Immunol 5: 730–737.
4. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, et al. (2009) Toll-like
receptor 3 mediates establishment of an antiviral state against hepatitis C virus in
hepatoma cells. J Virol 83: 9824–9834.
5. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA
viruses. Nature 441: 101–105.
6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of
double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Nature 413: 732–738.
7. Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate
receptors in infection and immunity. Immunity 34: 637–650.
8. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 59-Triphosphate
RNA is the ligand for RIG-I. Science 314: 994–997.
9. Vercammen E, Staal J, Beyaert R (2008) Sensing of viral infection and
activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21:
13–25.
10. Xagorari A, Chlichlia K (2008) Toll-like receptors and viruses: induction of
innate antiviral immune responses. Open Microbiol J 2: 49–59.
11. Johnsen IB, Nguyen TT, Ringdal M, Tryggestad AM, Bakke O, et al. (2006)
Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate
antiviral signaling. EMBO J 25: 3335–3346.
12. de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, et al. (2005)
Recognition of double-stranded RNA by human toll-like receptor 3 and
downstream receptor signaling requires multimerization and an acidic pH. J Biol
Chem 280: 38133–38145.
13. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr. (2008) Innate
immunity induced by composition-dependent RIG-I recognition of hepatitis C
virus RNA. Nature 454: 523–527.
14. Loo YM, Owen DM, Li K, Erickson AL, Johnson CL, et al. (2006) Viral and
therpeutic control of interferon beta promoter stimulator 1 during hepatitis C
virus infection. ProcNatlAcadSci USA 103: 6001–6006.
15. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif
is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis
C virus. Nature 437: 1167–1172.
16. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ (2005) Hepatitis C virus protease
NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria
to evade innate immunity. ProcNatlAcadSci USA 102: 17717–17722.
17. Li K, Chen Z, Kato N, Gale M, Jr., Lemon SM (2005) Distinct poly-I:C and
virus-activated interferon signaling pathways in hepatocytes. J BiolChem 280:
16739–16747.
18. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon ACM, et al. (2005) Immune
evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the TLR3
adaptor protein TRIF. Proc Natl Acad Sci U S A 102: 2992–2997.
19. Targett-Adams P, Boulant S, McLauchlan J (2008) Visualization of double-
stranded RNA in cells supporting hepatitis C virus RNA replication. J Virol 82:
2182–2195.
20. Limmon GV, Arredouani M, McCann KL, Corn Minor RA, Kobzik L, et al.
(2008) Scavenger receptor class-A is a novel cell surface receptor for double-
stranded RNA. FASEB J 22: 159–167.
21. Dieudonne A, Torres D, Blanchard S, Taront S, Jeannin P, et al. (2012)
Scavenger receptors in human airway epithelial cells: role in response to double-
stranded RNA. PLoS One 7: e41952.
22. DeWitte-Orr SJ, Collins SE, Bauer CM, Bowdish DM, Mossman KL An
accessory to the ‘Trinity’: SR-As are essential pathogen sensors of extracellular
dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS
Pathog 6: e1000829.
23. Yamashita M, Chattopadhyay S, Fensterl V, Saikia P, Wetzel JL, et al. (2012)
Epidermal growth factor receptor is essential for toll-like receptor 3 signaling. Sci
Signal 5: ra50.
24. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, et al.
(2008) Interferon signaling and treatment outcome in chronic hepatitis C. Proc
Natl Acad Sci U S A 105: 7034–7039.
25. Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D, et al. (2009) Visualizing
hepatitis C virus infections in human liver by two-photon microscopy.
Gastroenterology 137: 1448–1458.
MSR1 Facilitates TLR3 Sensing of Hepatitis C Virus
PLOS Pathogens | www.plospathogens.org 13 May 2013 | Volume 9 | Issue 5 | e100334526. Sumpter R, Jr., Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating
intracellular antiviral defense and permissiveness to hepatitis C virus RNA
replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689–2699.
27. Yi M, Lemon SM (2004) Adaptive mutations producing efficient replication of
genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol 78: 7904–7915.
28. Li K, Li NL, Wei D, Pfeffer SR, Fan M, et al. (2012) Activation of chemokine
and inflammatory cytokine response in hepatitis C virus-infected hepatocytes
depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded
RNA intermediates. Hepatology 55: 666–675.
29. Tuplin A, Evans DJ, Simmonds P (2004) Detailed mapping of RNA secondary
structures in core and NS5B-encoding region sequences of hepatitis C virus by
RNase cleavage and novel bioinformatic prediction methods. J GenVirol 85:
3037–3047.
30. Kato N, Ikeda M, Mizutani T, Sugiyama K, Noguchi M, et al. (1996)
Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes.
Japanese Journal of Cancer Research (Amsterdam) 87: 787–792.
31. Leonard JN, Ghirlando R, Askins J, Bell JK, Margulies DH, et al. (2008) The
TLR3 signaling complex forms by cooperative receptor dimerization. Proc Natl
Acad Sci U S A 105: 258–263.
32. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, et al. (1990) Type
I macrophage scavenger receptor contains alpha-helical and collagen-like coiled
coils. Nature 343: 531–535.
33. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, et al. (2012)
Stabilization of hepatitis C RNA by an Ago2-miR-122 complex. Proc Natl Acad
Sci U S A 109: 941–946.
34. Anachi RB, Siegel DL, Baum J, Brodsky B (1995) Acid destabilization of a triple-
helical peptide model of the macrophage scavenger receptor. FEBS Lett 368:
551–555.
35. Ma Y, Anantpadma M, Timpe JM, Shanmugam S, Singh SM, et al. (2011)
Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by
interacting with both structural and nonstructural proteins. J Virol 85: 86–97.
36. Li Y, Masaki T, Yamane D, McGivern DR, Lemon SM (2013) Competing and
noncompeting activities of miR-122 and the 59 exonuclease Xrn1 in regulation
of hepatitis C virus replication. Proc Natl Acad Sci U S A 110: 1881–1886.
37. Kannan RP, Hensley LL, Evers L, Lemon SM, McGivern DR (2011) Hepatitis
C virus infection causes cell cycle arrest at the level of entry to mitosis. J Virol 85:
7989–8001.
38. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, et al. (1997) A role
for macrophage scavenger receptors in atherosclerosis and susceptibility to
infection. Nature 386: 292–296.
39. Yew KH, Carsten B, Harrison C (2010) Scavenger receptor A1 is required for
sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells. Mol
Immunol 47: 883–893.
40. Freeman M, Ashkenas J, Rees DJ, Kingsley DM, Copeland NG, et al. (1990) An
ancient, highly conserved family of cysteine-rich protein domains revealed by
cloning type I and type II murine macrophage scavenger receptors. Proc Natl
Acad Sci U S A 87: 8810–8814.
41. Doi T, Higashino K, Kurihara Y, Wada Y, Miyazaki T, et al. (1993) Charged
collagen structure mediates the recognition of negatively charged macromole-
cules by macrophage scavenger receptors. J Biol Chem 268: 2126–2133.
42. Doi T, Kurasawa M, Higashino K, Imanishi T, Mori T, et al. (1994) The
histidine interruption of an alpha-helical coiled coil allosterically mediates a pH-
dependent ligand dissociation from macrophage scavenger receptors. J Biol
Chem 269: 25598–25604.
43. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, et al. (2010)
Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce
interferon, and inhibit infection. Proc Natl Acad Sci U S A 107: 7625–7626.
44. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for
subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001–
13014.
45. Ikeda M, Sugiyama K, Mizutani T, Tanaka T, Tanaka K, et al. (1998) Human
hepatocyte clonal cell lines that support persistent replication of hepatitis C virus.
Virus Res 56: 157–167.
46. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral
genome. Nature Medicine 11: 791–796.
47. Yi M, Ma Y, Yates J, Lemon SM (2007) Compensatory mutations in E1, p7,
NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric
hepatitis C virus. J Virol 81: 629–638.
48. Ma Y, Yates J, Liang Y, Lemon SM, Yi M (2008) NS3 helicase domains
involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82:
7624–7639.
49. Shimakami T, Yamane D, Welsch C, Hensley L, Jangra RK, et al. (2012) Base-
pairing between Hepatitis C Virus RNA and miR-122 39 of its Seed Sequence is
Essential for Genome Stabilization and Production of Infectious Virus. J Virol
86(13): 7372–7383.
50. Lin R, Genin P, Mamane Y, Hiscott J (2000) Selective DNA binding and
association with the CREB binding protein coactivator contribute to differential
activation of alpha/beta interferon genes by interferon regulatory factors 3 and
7. Mol Cell Biol 20: 6342–6353.
51. Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, et al. (2002)
Activation of the interferon-beta promoter during hepatitis C virus RNA
replication. Viral Immunol 15: 29–40.
52. Akagi T, Sasai K, Hanafusa H (2003) Refractory nature of normal human
diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl
Acad Sci U S A 100: 13567–13572.
53. Dansako H, Naganuma A, Nakamura T, Ikeda F, Nozaki A, et al. (2003)
Differential activation of interferon-inducible genes by hepatitis C virus core
protein mediated by the interferon stimulated response element. Virus Res 97:
17–30.
54. Naganuma A, Dansako H, Nakamura T, Nozaki A, Kato N (2004) Promotion of
microsatellite instability by hepatitis C virus core protein in human non-
neoplastic hepatocyte cells. Cancer Res 64: 1307–1314.
55. Dansako H, Ikeda M, Ariumi Y, Wakita T, Kato N (2009) Double-stranded
RNA-induced interferon-beta and inflammatory cytokine production modulated
by hepatitis C virus serine proteases derived from patients with hepatic diseases.
Arch Virol 154: 801–810.
56. Dansako H, Naka K, Ikeda M, Kato N (2005) Hepatitis C virus proteins exhibit
conflicting effects on the interferon system in human hepatocyte cells. Biochem
Biophys Res Commun 336: 458–468.
57. Dansako H, Ikeda M, Kato N (2007) Limited suppression of the interferon-beta
production by hepatitis C virus serine protease in cultured human hepatocytes.
Febs J 274: 4161–4176.
58. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, et al. (2011)
CDD: a Conserved Domain Database for the functional annotation of proteins.
Nucleic Acids Res 39: D225–229.
MSR1 Facilitates TLR3 Sensing of Hepatitis C Virus
PLOS Pathogens | www.plospathogens.org 14 May 2013 | Volume 9 | Issue 5 | e1003345